Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Finnish national molecularly guided study of abemaciclib in advanced solid tumors
2021-000689-14Phase 2Active
- Sponsor
- Helsinki University Hospital
- Start
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of abemaciclib in Nonhematologic neoplasms and lymphoma, sponsored by Helsinki University Hospital. Primary endpoint: Disease control rate. Started Aug 2021; status: active.
02
Drugs
abemaciclib
03
Conditions
Nonhematologic neoplasmslymphoma
Beyond the preview
Go deeper on 2021-000689-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-000689-14.